BRC-002

DRUG3 trials

Sponsors

University of California, San Diego, University of Colorado, Denver, Biopharmaceutical Research Company

Conditions

Complex Regional Pain SyndromeHealthy Adult ParticipantsRestless Leg Syndrome

Phase 1

The Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain Syndrome

RecruitingNCT06393101

University of California, San DiegoComplex Regional Pain Syndrome

Start: 2024-06-01End: 2029-06-01Target: 52Updated: 2024-06-07

Evaluation of BRC-002 Safety, Tolerability, Pharmacokinetics, and Food Effects in Healthy Participants

Enrolling by invitationNCT07699120

Biopharmaceutical Research CompanyHealthy Adult Participants

Start: 2026-06-15End: 2026-11-01Target: 50Updated: 2026-07-13

Phase 2

Tolerability and Efficacy of CBD Extract for RLS Treatment

Not yet recruitingNCT07224932

University of Colorado, DenverRestless Leg Syndrome

Start: 2025-12-19End: 2026-02-25Target: 60Updated: 2025-11-13